MD Farma Closes Series A Funding and Changes Name to Corganics as the Company Expands Clinical Cannabinoid (CBD) Product Lines Sold Only in Healthcare Facilities

from Venture Capital Access Online: Latest Venture Capital and Private Equity News https://ift.tt/3lkRsV6
via IFTTT